Cks Pharma Labs Private Limited
Cks Pharma Labs Private Limited is a Private Non-govt company company incorporated in 2010 and based in Andhra Pradesh, India. Cks Pharma Labs Private Limited operates in Pharmaceuticals & Chemicals (NIC 24100) with authorized capital of ₹3.00 Cr and paid-up capital of ₹2.37 Cr. For 2020-21, the company reported revenue of ₹17.43 Cr and a net loss of ₹2.78 Cr. RegisterKaro's provisional Compliance Health Score for the company is 67/100 (grade C), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Cks Pharma Labs Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +6d | filed |
| MGT-7 | FY2024-25 | 20 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +22d | filed |
| MGT-7 | FY2023-24 | 22 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 21 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Cks Pharma Labs Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 837190690 | ICICI Bank Ltd(Bank) | ₹10.04 Cr | 27 Jan 2023 | Open |
| 654656764 | HDFC Bank Ltd(Bank) | ₹6.40 Cr | 27 Jan 2021 | Satisfied |
| 988840445 | Kotak Mahindra Bank Ltd(Bank) | ₹8.54 Cr | 27 Jan 2023 | Open |
| 239055149 | HDFC Bank Ltd(Bank) | ₹20.90 Cr | 04 Jul 2022 | Satisfied |
Charge IDs, lenders & amounts for Cks Pharma Labs Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2020-21 | — | ||||
| 2018-19 | — | ||||
| 2017-18 | — |
Detailed Financials
3 FYs| Line item | 2020-21 | 2018-19 | 2017-18 |
|---|---|---|---|
| Income statement | |||
| Revenue from operations | |||
| Other income | |||
| Total income | |||
| Total expenses | |||
| Profit before tax | |||
| Profit / (Loss) after tax | |||
| Balance sheet | |||
| Equity / Net worth | |||
| Borrowings | |||
| Current liabilities | |||
| Total liabilities | |||
| Current assets | |||
| Cash & equivalents | |||
| Total assets | |||
| Employees | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2020-21 | +38.0% | — | — | |
| Profit after Tax2020-21 | -270.0% | — | — | |
| Net Worth2020-21 | -275.0% | — | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2017-18 | +6.21% | — | +43.47% | +3.94% | 11.03 | |||
| 2018-19 | +4.39% | +55.63% | +3.92% | +4.33% | 0.90 | |||
| 2020-21 | -15.92% | +65.58% | — | -29.11% | — |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 1 | 1,80,13,004 | 65.70% |
| Institutional Investors | 3 | 23,41,920 | 8.54% |
| Public & Others | 61 | 70,61,136 | 25.76% |
Promoter, institutional & public holding for Cks Pharma Labs Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
6 peersEvents & timeline
6External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.